The American College of Chest Physicians (CHEST) was awarded a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to improve diagnostic excellence in interstitial lung disease (ILD).
Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets
Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in